Although these chemoresistant sublines are capable of forming more sphere cells than their parental cancer cells, we treated these chemoresistant cancer cells with shikonin and examined by sphere-forming assay as well as evaluated the expression of stemness genes (Nonog and Oct4) to define the effect of shikonin anti-cancer activity. This evidence concerns the gene POU5F1 and cancer.